Cons Outweigh Potential Pros to BPC Plan on Stem Cells & FDA

BPC-report-stem-cels

There is considerable interest in FDA regulatory reform here in the U.S. for stem cell therapies. The goal is to get new treatments to patients faster, but is there a way to do that without sacrificing proven safety and efficacy? You need convincing data on both safety and efficacy or speed becomes dangerous. Bipartisan Policy Center […]

Cons Outweigh Potential Pros to BPC Plan on Stem Cells & FDA Read More »